Sprint Bioscience (Sweden) Volatility
| SPRINT Stock | SEK 2.14 0.12 5.94% |
Sprint Bioscience is abnormally volatile given 3 months investment horizon. Sprint Bioscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.78% are justified by taking the suggested risk. Use Sprint Bioscience Coefficient Of Variation of 596.21, risk adjusted performance of 0.1422, and Semi Deviation of 2.1 to evaluate company specific risk that cannot be diversified away.
Sharpe Ratio = 0.1758
| High Returns | Best Equity | |||
| Good Returns | SPRINT | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.84 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.78 actual daily | 56 56% of assets have lower returns |
Risk-Adjusted Return
| 0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Sprint Bioscience is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sprint Bioscience by adding it to a well-diversified portfolio.
Key indicators related to Sprint Bioscience's volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Sprint Bioscience Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Sprint daily returns, and it is calculated using variance and standard deviation. We also use Sprint's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Sprint Bioscience volatility.
Sprint |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Sprint Bioscience can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Sprint Bioscience at lower prices to lower their average cost per share. Similarly, when the prices of Sprint Bioscience's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities. Main indicators related to Sprint Bioscience's market risk premium analysis include:
Beta 3.78 | Alpha 2.36 | Risk 15.84 | Sharpe Ratio 0.18 | Expected Return 2.78 |
Moving together with Sprint Stock
| 0.69 | TEL2-A | Tele2 AB | PairCorr |
| 0.73 | BRAV | Bravida Holding AB | PairCorr |
| 0.68 | SWED-A | Swedbank AB | PairCorr |
| 0.66 | INDU-C | Industrivarden AB ser | PairCorr |
| 0.65 | INDU-A | Industrivarden AB ser | PairCorr |
| 0.73 | BIOA-B | BioArctic AB | PairCorr |
Moving against Sprint Stock
| 0.74 | ERMA | Enorama Pharma AB | PairCorr |
| 0.62 | KAR | Karnov Group AB | PairCorr |
| 0.57 | NNH | New Nordic Healthbrands | PairCorr |
| 0.55 | EPRO-B | Electrolux Professional | PairCorr |
| 0.53 | BEIJ-B | Beijer Ref AB | PairCorr |
| 0.41 | THULE | Thule Group AB | PairCorr |
Sprint Bioscience Market Sensitivity And Downside Risk
Sprint Bioscience's beta coefficient measures the volatility of Sprint stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Sprint stock's returns against your selected market. In other words, Sprint Bioscience's beta of 3.78 provides an investor with an approximation of how much risk Sprint Bioscience stock can potentially add to one of your existing portfolios. Sprint Bioscience AB is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Sprint Bioscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Sprint Bioscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Sprint Bioscience Demand TrendCheck current 90 days Sprint Bioscience correlation with market (Dow Jones Industrial)Sprint Bioscience Volatility and Downside Risk
Sprint standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Sprint Bioscience Stock Volatility Analysis
Volatility refers to the frequency at which Sprint Bioscience stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Sprint Bioscience's price changes. Investors will then calculate the volatility of Sprint Bioscience's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Sprint Bioscience's volatility:
Historical Volatility
This type of stock volatility measures Sprint Bioscience's fluctuations based on previous trends. It's commonly used to predict Sprint Bioscience's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Sprint Bioscience's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Sprint Bioscience's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sprint Bioscience Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Sprint Bioscience Projected Return Density Against Market
Assuming the 90 days trading horizon the stock has the beta coefficient of 3.7772 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Sprint Bioscience will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sprint Bioscience or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sprint Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sprint stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Predicted Return Density |
| Returns |
What Drives a Sprint Bioscience Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Sprint Bioscience Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Sprint Bioscience is 568.93. The daily returns are distributed with a variance of 250.9 and standard deviation of 15.84. The mean deviation of Sprint Bioscience AB is currently at 5.78. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.79
α | Alpha over Dow Jones | 2.36 | |
β | Beta against Dow Jones | 3.78 | |
σ | Overall volatility | 15.84 | |
Ir | Information ratio | 0.16 |
Sprint Bioscience Stock Return Volatility
Sprint Bioscience historical daily return volatility represents how much of Sprint Bioscience stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company accepts 15.84% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7472% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sprint Stock performing well and Sprint Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sprint Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SPAGO | 4.61 | 0.40 | 0.04 | (0.35) | 4.99 | 9.09 | 44.42 | |||
| ATORX | 7.23 | (2.01) | 0.00 | 0.94 | 0.00 | 11.76 | 86.58 | |||
| ACOU | 4.53 | 0.37 | 0.06 | (0.31) | 4.33 | 12.02 | 25.77 | |||
| SPEC | 3.80 | (0.94) | 0.00 | 5.78 | 0.00 | 6.25 | 39.76 | |||
| PILA | 4.06 | (0.66) | 0.00 | 6.96 | 0.00 | 9.82 | 51.16 | |||
| LPGO | 8.32 | (2.09) | 0.00 | (3.39) | 0.00 | 7.50 | 118.05 | |||
| SIMRIS-B | 7.94 | 0.62 | 0.04 | 0.63 | 11.09 | 15.24 | 104.57 | |||
| ACTI | 2.34 | (0.66) | 0.00 | 0.58 | 0.00 | 5.89 | 18.88 | |||
| ONCOZ | 3.66 | 0.15 | 0.03 | 0.76 | 3.57 | 9.72 | 24.41 |
About Sprint Bioscience Volatility
Volatility is a rate at which the price of Sprint Bioscience or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Sprint Bioscience may increase or decrease. In other words, similar to Sprint's beta indicator, it measures the risk of Sprint Bioscience and helps estimate the fluctuations that may happen in a short period of time. So if prices of Sprint Bioscience fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism. Sprint Bioscience AB was founded in 2009 and is based in Huddinge, Sweden. Sprint Bioscience operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.
Sprint Bioscience's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Sprint Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Sprint Bioscience's price varies over time.
3 ways to utilize Sprint Bioscience's volatility to invest better
Higher Sprint Bioscience's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Sprint Bioscience stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Sprint Bioscience stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Sprint Bioscience investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Sprint Bioscience's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Sprint Bioscience's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Sprint Bioscience Investment Opportunity
Sprint Bioscience AB has a volatility of 15.84 and is 21.12 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than Sprint Bioscience. You can use Sprint Bioscience AB to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Sprint Bioscience to be traded at kr2.68 in 90 days.Poor diversification
The correlation between Sprint Bioscience AB and DJI is 0.77 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and DJI in the same portfolio, assuming nothing else is changed.
Sprint Bioscience Additional Risk Indicators
The analysis of Sprint Bioscience's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Sprint Bioscience's investment and either accepting that risk or mitigating it. Along with some common measures of Sprint Bioscience stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1422 | |||
| Market Risk Adjusted Performance | 0.6703 | |||
| Mean Deviation | 5.36 | |||
| Semi Deviation | 2.1 | |||
| Downside Deviation | 3.83 | |||
| Coefficient Of Variation | 596.21 | |||
| Standard Deviation | 14.93 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Sprint Bioscience Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Sprint Bioscience as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Sprint Bioscience's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Sprint Bioscience's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Sprint Bioscience AB.
Complementary Tools for Sprint Stock analysis
When running Sprint Bioscience's price analysis, check to measure Sprint Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sprint Bioscience is operating at the current time. Most of Sprint Bioscience's value examination focuses on studying past and present price action to predict the probability of Sprint Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sprint Bioscience's price. Additionally, you may evaluate how the addition of Sprint Bioscience to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |